Arcutis and Huadong Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Greater China and Southeast Asia : vimarsana.com

Arcutis and Huadong Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Greater China and Southeast Asia

Arcutis and Huadong Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Greater China and Southeast Asia

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Macau , Taiwan , Singapore , Indonesia , United States , Hangzhou , Zhejiang , China , Malaysia , Liang Lu , Sichuan , Laos , Vietnam , Republic Of , Brunei , Hong Kong , Cambodia , Huadong , Guangdong , Thailand , Philippines , Chinese , Mediaamanda Sheldon , Frank Watanabe , Investorseric Mcintyre , Nasdaq , Huadong Medicine Co Ltd , Arcutisarcutis Biotherapeutics Inc , Drug Administration , Hangzhou Zhongmei Huadong Pharmaceutical Co , Exchange Commission , Arcutis Biotherapeutics Inc , Twitter , Head Of Corporate Communications , Facebook , Greater China , Southeast Asia , Chief Executive Officer , Topical Roflumilastarcutis , Huadong Medicine , Patient Centered , Science Driven , Looking Statementsarcutis , Private Securities Litigation Reform Act , Eric Mcintyre ,